Children's Brain Tumor Network https://validator.w3.org/feed/docs/rss2.html Advancing DMG Drug Discovery with an Organoid-Based Toolkit From Data to Treatment: AI-Driven Identification of Molecular Targets and Bio-Inspired Therapeutics for Pediatric Glioma Bayer NTRK Fusion Project Analysis of outcomes in recently treated subjects with DIPG Multi-Tensor Decompositions for Personalized Pediatric Glioma Diagnostics and Prognostics Integrative analysis of childhood cancers Project Hope, High-Grade Glioma-Omics in Pediatric and AYA Clinical and molecular characterization of rare and newly defined brain tumor entities Including CNS sarcomas, BCOR altered tumors, astroblastomas/MN-1 altered tumors. PLAG1 altered tumors and histologically ambiguous/unclassifiable brain tumors Development of Cancer Immunoprevention in a High-Risk Population of CMMRD: Characterization of Frameshift Neoantigens in Mismatch Repair Deficient Individuals Profiling non-canonical open reading frames in pediatric brain cancer The Role of Histone Chaperones in H3.3K27M-altered Pediatric Diffuse Midline Glioma iPC EU Horizon 2020 – Individualized Paediatric Cure: Cloud-based virtual-patient models for precision paediatric oncology Mechanism of action and efficacy of ONC201 and ONC206 in DMG preclinical models Molecular and Spatial Insights into Treatment Failure in Pediatric Low-Grade Gliomas Rapid Molecular Central Nervous System Tumor Diagnosis Leveraging Deep Learning to Decipher Single-cell Epigenetic Regulation in Diffuse Midline Glioma and Ependymoma Systems biology integration of single-cell and spatial omics data to dissect tumor and tumor microenvironment interaction map of atypical teratoid rhabdoid tumors. The Proteomic Landscape of Low-Grade Glioma (LGG) Medulloblastoma subgroups stratification using transcriptome and RNA modification landscape An immuno-epigenomic approach to identify therapeutic opportunities for Paediatric High-Grade Gliomas Maternal Microchimerism in Human Brain Understanding the effect of mismatch repair deficiency on the alternative lengthening of telomeres Mechanisms of medulloblastoma formation Genetic Susceptibility to Medulloblastoma Genomic Analysis of Oligodendrogilomas across the pediatrics, adolescents and adults Evaluation of immunosignature profile in medulloblastoma Development of Preclinical Models of Pediatric Ependymoma Center for Pediatric Tumor Cell Atlas ENPP1 inhibition in models of medulloblastoma Personalized therapy for high-risk ependymoma of childhood Delineating pediatric glioma progression using single-nuclei sequencing Identifying the cells of origins of brain tumors using somatic mutations Targeting regions of converging synteny in pediatric and canine glioma Impeding LIN28 function in ATRT Investigating the Metabolic Hallmarks of Oligodendroglioma Identification of circulating noncoding RNAs and metabolites in cerebrospinal fluid (CSF) in medulloblastoma patients Regional Response to ONC201 in Pediatric High-Grade Glioma Targeting medulloblastoma by regulating RNA binding proteins Therapeutic targeting of the blood-brain barrier in pediatric malignant brain tumors Genomic Analysis of Chordomas across the pediatrics, adolescents and adults Investigating disease mechanism in Adamantinomatous Craniopharyngioma using new cell line models. The role of genetic factors in ependymoma susceptibility Using whole genome bisulfite sequencing to identify novel therapeutic targets in DIPG and ATRT Defining the role of the histone 3 (H3.3G34R) mutation in the pathogenesis of pediatric high astrocytoma Home Circular RNAs in Medulloblastoma Elucidate potential therapeutic targets in H3.3G34 mutant pHGG cells Elucidating the role of driver mutations in pediatric High Grade Glioma Molecular and functional characterization of childhood supratentorial ependymoma News